Jim Jordan Has Change of Heart on Disastrous One Agency Act Proposal
April 30, 2025 – Following news that Jim Jordan and the House Judiciary Committee have decided to cut a misguided proposal in the reconciliation bill that would have transferred the Federal Trade Commission’s (FTC) antitrust capacity to the Department of Justice (DOJ)—effectively repealing the government’s authority to police unfair methods of competition and leaving ongoing cases against pharmacy benefit managers and Big Tech in limbo—the American Economic Liberties Project released the following statement.
Why Does Jim Jordan Hate Fairness?
April 28, 2025 – In response to news that the House Judiciary markup of the Republican mega bill would transfer the antitrust capacity of the Federal Trade Commission to the Department of Justice—effectively repealing the government’s authority to police unfair methods of competition, which is exclusive to the FTC, and leaving AG Pam Bondi to decide the fate of ongoing FTC antitrust cases, including a high-profile case against the “Big Three” pharmacy benefit managers—the American Economic Liberties Project released the following statement.
With Meador Confirmed, FTC is Back to Five Person Commission and Should Pursue Aggressive Enforcement Agenda
April 10, 2025 – Following news that the United States Senate has confirmed Mark Meador to be the next Commissioner at the Federal Trade Commission (FTC), the American Economic Liberties Project released the following statement.
Economic Liberties Urges Trump Administration to Maximize Transparency in Negotiations During 90-Day Tariff Pause
April 9, 2025 – Today, as the Trump administration announced a 90-day pause in implementation of its “Reciprocal Tariffs,” the Rethink Trade program at the American Economic Liberties Project released the following statement.
Alabama Pharmacists Secure PBM Reform
April 9, 2025 – In response to the news that the Alabama Legislature unanimously passed the Community Pharmacy Relief Act (SB252), which – pending Governor Kay Ivey’s signature – will require pharmacy benefit managers (PBMs) to reimburse independent pharmacies according to their acquisition and labor costs, the American Economic Liberties Project released the following statement.